← Back to CMMB

Chemomab Therapeutics Ltd. - American Depositary Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2025Filed 14/08/2025Mar 2025Filed 14/08/2025Jun 2024Filed 14/08/2025Mar 2024Filed 14/08/2025Jun 2023Filed 21/08/2024Mar 2023Filed 21/08/2024Sep 2022Filed 10/11/2022Jun 2022Filed 14/08/2023
−$2.1−$3.3−$3.6−$3.9−$8−$8.8−$8.1−$6.2
$0.01$0.04$0.04$0.04$0.03
286222221229228

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.